3 Results for "

Phaeosphaeria

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Phaeosphaeria" in MCE Product Catalog:

Methyl mycophenolate
Methyl mycophenolate
0 Images
Cat. No.: HY-113972
CAS No.: 31858-66-9
Purity:  ≥99.0%
Category:  

Microorganisms Monophenols Marine natural products Phenols Disease Research Fields Inflammation/Immunology Marine microorganism

Target:  

Others

Methyl mycophenolate is a methyl ester of mycophenolic acid and is also found in marine-derived fungus Phaeosphaeria spartinae .
loading...
    loading...
View All Sizes
Phaeosphaone D
Phaeosphaone D
0 Images
Cat. No.: HY-N10285
CAS No.: 2640137-78-4
Category:  

Infection Alkaloids Microorganisms Disease Research Fields Indole Alkaloids

Target:  

Tyrosinase

Phaeosphaone D is a thiodiketopiperazine alkaloid compound isolated from Phaeosphaeria fuckelii, an endophytic fungus. Phaeosphaone D displays mushroom tyrosinase inhibitory activity with an IC50 value of 33.2 μM .
loading...
    loading...
View All Sizes
Methyl mycophenolate (Standard)
Methyl mycophenolate (Standard)
0 Images
Cat. No.: HY-113972R
CAS No.: 31858-66-9
Category:  

Microorganisms Monophenols Marine natural products Phenols Marine microorganism

Target:  

Reference Standards Others

Avanafil (Standard) is the analytical standard of Avanafil. This product is intended for research and analytical applications. Avanafil (TA-1790) is a potent and selective phosphodiesterase-5 (PDE-5) inhibitor with IC50 values of 5.2 nM, 630 nM, 5700 nM, 6200 nM, 12000 nM, 27000 nM, 51000 nM and 53000 nM for PDE-5, PDE-6, PDE-4, PDE-10, PDE-8, PDE-7, PDE-2 and PDE-1, respectively. Avanafil activates NO/cGMP/PKG signaling-pathway to decrease loss in BMD, bone atrophy, and oxidative stress. Avanafil inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels. Avanafil can be used for the research of erectile dysfunction and osteoporosis .
loading...
    loading...
View All Sizes
Assay Types